由STAT5激活瘤基因诱导的 Kostatin M促进了血液性恶性瘤的疾病进展
Michael Rassner1, Tony Andreas Müller1,2, Kirstyn Anne Crossley1,3
1Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Signal transduction and targeted therapy
|December 10, 2025
概括
瘤基因突变激活 Kostatin M (OSM),驱动血液恶性瘤的进展和免疫抑制. 针对OSM信号提供了一个有前途的治疗策略,用于骨髓增殖性瘤和相关的血液癌症.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 血液性恶性瘤中的瘤突变会影响瘤的微观环境.
- 了解这些相互作用对于开发有效疗法至关重要.
研究的目的:
- 调查 Kostatin M (OSM) 在将瘤突变与瘤微环境重塑和免疫抑制的关联中的作用.
- 评估OSM信号作为血液恶性瘤的治疗点.
主要方法:
- 使用了具有特定致癌突变的小鼠模型 (JAK2 p.V617F,FLT3-ITD,BCR::ABL1).
- 分析了骨髓 stromal 细胞上的 OSM 受体表达.
- 评估T细胞数量,抑制性受体表达和细胞因子概况.
- 对T细胞进行了转录基因分析.
- 从药理上评估了OSM抑制的作用.
主要成果:
- 激活STAT5的瘤基因诱导OSM,促进疾病进展和免疫抑制.
- OSM重编程骨髓层细胞,导致T细胞通过IL-6和MCP-1耗尽.
- OSM过度表达减少T细胞数量,增加抑制受体,并促进髓状细胞扩张,抑制T细胞.
- 在JAK2 p.V617F小鼠模型中,OSM的遗传删除改善了疾病表型.
- 药理上的OSM抑制降低了疾病活性和细胞因子的产生.
结论:
- OSM是一个关键的调解者,将瘤性STAT5激活与微环境重塑和血液性恶性瘤中的免疫抑制联系起来.
- 针对OSM信号提供了一个潜在的治疗策略,用于骨髓增殖性瘤和相关癌症.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


